EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics.

Ireton RC, Chen J
Curr Cancer Drug Targets. 2005 5 (3): 149-57

PMID: 15892616 · DOI:10.2174/1568009053765780

MeSH Terms (6)

Animals Antineoplastic Agents Humans Neoplasms Neovascularization, Pathologic Receptor, EphA2

Connections (2)

This publication is referenced by other Labnodes entities:

Links